Publications

• Global patterns of hemophilia drug trials, hemophilia care, and health care measures.
  Res Pract Thromb Haemost Volume: 9 Page(s): 102714
  02/01/2025 Authors: Fedewa SA; Valentino LA; Koo A; Cafuir L; Gillespie TW; Buckner TW; Tran DQ; Antun A; Kempton CL
• Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.
  Blood Adv Volume: 8 Page(s): 5896 - 5905
  11/26/2024 Authors: Poston JN; Bryan C; von Drygalski A; Al Banaa K; Zhou JY; Parnes A; Chen EC; Khan O; Ellsworth P; Cafuir L
• Women and girls' participation in haemophilia clinical trials.
  Haemophilia Volume: 30 Page(s): 1440 - 1443
  11/01/2024 Authors: Fedewa SA; Cafuir L; Valentino LA; Koo A; Antun A; Kempton CL
• Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophilia.
  J Racial Ethn Health Disparities Volume: 11 Page(s): 1394 - 1404
  06/01/2024 Authors: Fedewa SA; Buckner TW; Parks SG; Tran DQ; Cafuir L; Antun AG; Mattis S; Kempton CL
• Race and ethnicity reporting and representation in hemophilia clinical trials.
  Blood Adv Volume: 8 Page(s): 2351 - 2360
  05/28/2024 Authors: Fedewa SA; Valentino LA; Koo A; Cafuir L; Tran DQ; Antun A; Kempton CL
• Racial and ethnic differences in reported haemophilia death rates in the United States.
  Haemophilia Volume: 29 Page(s): 1410 - 1418
  11/01/2023 Authors: Fedewa SA; Payne AB; Tran D; Cafuir L; Antun A; Kempton CL
• Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study.
  EJHaem Volume: 3 Page(s): 457 - 462
  05/01/2022 Authors: Scott LC; Li J; Cafuir LA; Gaddh M; Kempton CL
• Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study.
  J Thromb Haemost Volume: 20 Page(s): 857 - 865
  04/01/2022 Authors: Kleiboer B; Layer MA; Cafuir LA; Cuker A; Escobar M; Eyster ME; Kraut E; Leavitt AD; Lentz SR; Quon D
• Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult males with Hemophilia A without inhibitors.
  J Med Econ Volume: 25 Page(s): 984 - 992
  01/01/2022 Authors: Cafuir L; Estrin A; Chen E; Hinds D; Prince P; Thorburn J; Mead H; Kempton CL
• Outcomes of direct oral anticoagulant- and warfarin-associated hemorrhage: A single center retrospective cohort study.
  Thromb Res Volume: 189 Page(s): 128 - 131
  05/01/2020 Authors: Cafuir L; Cheng E; Kempton C
• Emicizumab for hemophilia A without inhibitors.
  Expert Rev Hematol Volume: 12 Page(s): 515 - 524
  07/01/2019 Authors: Cafuir L; Kruse-Jarres R; Mancuso ME; Kempton CL
• Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab.
  J Immunother Cancer Volume: 6 Page(s): 11
  01/30/2018 Authors: Cafuir L; Lawson D; Desai N; Kesner V; Voloschin A
• Current and emerging factor VIII replacement products for hemophilia A.
  Ther Adv Hematol Volume: 8 Page(s): 303 - 313
  10/01/2017 Authors: Cafuir LA; Kempton CL
• The Runx3 distal transcript encodes an additional transcriptional activation domain.
  FEBS J Volume: 274 Page(s): 3429 - 3439
  07/01/2007 Authors: Chung DD; Honda K; Cafuir L; McDuffie M; Wotton D